NCT06764186
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06764186
Title A Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanced Breast Cancer Who Have Relapsed/Progressed on ET and CDK4/6 Inhibitor Reflecting Real World Clinical Practice in Spain (CAPItana)
Acronym CAPItana
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Research Site RECRUITING Alicante 03010 Spain Details
Research Site RECRUITING Barcelona 08003 Spain Details
Research Site RECRUITING Barcelona 08035 Spain Details
Research Site RECRUITING Barcelona 08036 Spain Details
Research Site RECRUITING Bilbao (Vizcaya) 48013 Spain Details
Research Site NOT_YET_RECRUITING Cáceres 10003 Spain Details
Research Site RECRUITING Córdoba 14004 Spain Details
Research Site RECRUITING Donostia / San Sebastian 20014 Spain Details
Research Site RECRUITING El Palmar 30120 Spain Details
Research Site RECRUITING Girona 17007 Spain Details
Research Site RECRUITING Madrid 28041 Spain Details
Research Site RECRUITING Oviedo 33011 Spain Details
Research Site RECRUITING Palma deMallorca 07010 Spain Details
Research Site RECRUITING Salamanca 37007 Spain Details
Research Site RECRUITING Santander 39008 Spain Details
Research Site RECRUITING Seville 41073 Spain Details
Research Site RECRUITING Valencia 46026 Spain Details
Research Site RECRUITING Zaragoza 50009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field